Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 5/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.41 |
| ▸ | NAAA | Q02083 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | NPC1 | O15118 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 1/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.38 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | ESR1 | P03372 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6203123 | 0.87 | CHRNB2 (0.40) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL18723046 | 0.83 | ZDHHC7 (0.39) | ALDH1A1ATMTSHRHCAR2NAAA | |
| SCHEMBL18723128 | 0.81 | ZDHHC7 (0.41) | ATMTSHRHCAR2NAAAEPHX1 | |
| SCHEMBL8908162 | 0.80 | CHRNB2 (0.58) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL16522415 | 0.79 | CHRNB2 (0.42) | TDP1LMNACHRM2CHRM4CHRM5 | |
| SCHEMBL14621748 | 0.78 | CHRNB2 (0.40) | ALDH1A1TSHRCHRM2CHRM4CHRM5 | |
| SCHEMBL872502 | 0.78 | — | — | |
| SCHEMBL10918173 | 0.77 | ALDH1A1 (0.52) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL288939 | 0.77 | ALDH1A1 (0.52) | ALDH1A1ATMTSHRHPGDHCAR2 | |
| SCHEMBL871326 | 0.77 | CHRNB2 (0.39) | CHRM2CHRM4CHRM5CHRM1CHRNB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9616099-B2 | Cyclosporin analogues for preventing or treating hepatitis C infection | ENANTA PHARMACEUTICALS, INC. (US) | 2017-04-11 | — | — | US | disclosed |
| US-20160136233-A1 | NOVEL CYCLOSPORIN ANALOGUES FOR PREVENTING OR TREATING HEPATITIS C INFECTION | ENANTA PHARM INC (US) | 2016-05-19 | — | — | US | disclosed |
| US-9221878-B2 | Cyclosporin analogues for preventing or treating hepatitis C infection | ENANTA PHARMACEUTICALS, INC. (US) | 2015-12-29 | — | — | US | disclosed |
| US-20150056165-A1 | NOVEL CYCLOSPORIN ANALOGUES FOR PREVENTING OR TREATING HEPATITIS C INFECTION | ENANTA PHARMACEUTICALS, INC. | 2015-02-26 | — | — | US | disclosed |
| EP-2280404-A2 | Metal complex dye for a photoelectrochemical cell | FUJIFILM Corporation (JP) | 2011-02-02 | — | — | EP | disclosed |
| EP-0692469-B1 | Process for recovering N,O-dialkylhydroxycarbamic acid ester | MITSUI PETROCHEMICAL IND (JP) | 1997-10-22 | — | — | EP | disclosed |
| EP-0581613-B1 | Process for preparing N,O-dialkylhydroxycarbamic acid esters | MITSUI PETROCHEMICAL IND (JP) | 1996-09-11 | — | — | EP | disclosed |
| US-5510511-A | REACTING HYDROXYLAMINE AND DIHYDROCARBYL CARBONATE WITH COOLING IN PRESENCE OF BASIC COMPOUND, ALKYLATING TO FORM N,O-DIALKYLHYDROXYCARBAMIC ACID ESTER | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1996-04-23 | — | — | US | disclosed |
| EP-0692469-A1 | Process for recovering N,O-dialkylhydroxycarbamic acid ester | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1996-01-17 | — | — | EP | disclosed |
| EP-0581613-A1 | Process for preparing N,O-dialkylhydroxycarbamic acid esters | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1994-02-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160136233-A1 | NOVEL CYCLOSPORIN ANALOGUES FOR PREVENTING OR TREATING HEPATITIS C INFECTION | HAVCR2, CHP1, MAVS | ALDH1A1 3792/4885ATM 4834/4885TSHR 4812/4885 |
| US-20150056165-A1 | NOVEL CYCLOSPORIN ANALOGUES FOR PREVENTING OR TREATING HEPATITIS C INFECTION | HAVCR2, CHP1, MAVS | ALDH1A1 3792/4885ATM 4834/4885TSHR 4812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.